Average Co-Inventor Count = 3.93
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Pittsburgh (13 from 1,860 patents)
2. University of Pennsylvania (1 from 2,595 patents)
3. Grandi, Paola (0 patent)
4. Glorioso Iii, Joseph C. (0 patent)
5. Cohen, Justus (0 patent)
6. Uchida, Hiroaki (0 patent)
13 patents:
1. 12414973 - Antigenically stealthed oncolytic viruses
2. 11883448 - Oncolytic HSV vector
3. 11419926 - Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors
4. 10851354 - TRPV1 modulatory gene product that affects TRPV1-specific pain behavioral responses identified in a functional screen of an HSV-based cDNA library
5. 10576115 - Oncolytic HSV vector
6. 10328136 - Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors
7. 10201575 - Oncolytic HSV vector
8. 10188686 - Oncolytic HSV vector
9. 10174341 - Non-toxic HSV vectors for efficient gene delivery applications and complementing cells for their production
10. 10172893 - Oncolytic HSV vector
11. 10160959 - TRPV1 modulatory gene product that affects TRPV1-specific pain behavioral responses identified in a functional screen of an HSV-based cDNA library
12. 9593347 - Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors
13. 9580699 - TRPV1 modulatory gene product that affects TRPV1-specific pain behavioral responses identified in a functional screen of an HSV-based cDNA library